(EMAILWIRE.COM, October 28, 2020 ) [134 pages Report] The aspiration and biopsy needles market is estimated to grow at a CAGR of 7.3% to reach USD 1,272 Million by 2024 from USD 894 Million in 2019.

What drives the market?

Rising Prevalence of Cancer
Cancer Awareness Initiatives Undertaken By Governments and Global Health Organizations
Increasing Preference for Minimally Invasive Biopsies

Factors such as the rising prevalence of cancer, initiatives undertaken by government and global health organizations, and the increasing preference for minimally invasive procedures are the major factors driving the growth of the aspiration and biopsy needle market.

Download a PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=71036825

North America accounted for the largest share of the aspiration and biopsy needles market in 2019

 This report covers the aspiration and biopsy needles market across four major geographies—North America, Europe, Asia Pacific, and the Rest of the World. North America commanded the largest share of the fine needle aspiration market in 2019. Factors such as the increasing prevalence of cancer in the US and Canada and cancer awareness initiatives undertaken by local governments and global health organizations in the North America region are the key factors driving market growth.

Key Market Players

CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Group Incorporated (US), Argon Medical Devices, Inc (US), INRAD Inc. (US), Somatex Medical Technologies (Germany), Stryker Corporation (US), Cardinal Health (US), Remington Medical (US), HAKKO CO.,LTD (Japan), and Merit Medical Systems (US) are some of the major players in the aspiration and biopsy needles market.

Request a Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=71036825

Key Questions Addressed in This Reports

What are the strategies adopted by the top market players in the aspiration and biopsy needles market to penetrate emerging markets?
Who are the major players offering fine needle aspiration across major geographies?
Emerging countries offer opportunities for the adoption of aspiration and biopsy needles. Will this scenario continue for the next five years?
What are the factors impacting the growth of aspiration & biopsy needles market globally?